NEW YORK (360Dx) – Avant Diagnostics on Wednesday said it has acquired an exclusive option to license Genetic Health Solution's patient-delivery technology platform.

Avant said it plans to use the platform to develop a personalized cancer patient management program that will combine blood biomarker monitoring and drug side effect profiles to help reduce negative drug side effects in cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.